Literature DB >> 18595190

Jervell and Lange-Nielsen syndrome in Norwegian children: aspects around cochlear implantation, hearing, and balance.

Geir Siem1, Andreas Früh, Trond P Leren, Ketil Heimdal, Erik Teig, Sten Harris.   

Abstract

OBJECTIVES: Jervell and Lange-Nielsen syndrome (JLNS) is a rare cause of autosomal recessive inherited deafness. JLNS patients are candidates for cochlear implantation, and represent a group that needs special attention and precautions. The aim of this article is to draw some guidelines for dealing with these patients, and to emphasize the importance of electrocardiography (ECG) screening of congenitally deaf patients. A probable vestibular dysfunction is also discussed.
DESIGN: Eight of 273 implanted children (2.9%) at Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway have been diagnosed with JLNS. All the children were evaluated with ECG, six of them before cochlear implantation. Auditory perception was evaluated with the littlEARS Auditory Questionnaire, or with a test battery developed at Rikshospitalet-Radiumhospitalet Medical Center. DNA sequencing was used to screen for mutations in the genes KCNQ1 and KCNE1. The cases are presented and discussed in a retrospective case review.
RESULTS: Two of the children are dead. The corrected QT (QTc) interval in the ECG was markedly prolonged in all the children (median QTc, 0.59 sec; range, 0.53-0.65). Six children have more than 1 yr experience with their cochlear implant. Four of them are performing average or above compared with the other implanted children. All the children have mutations in the KCNQ1 gene. Six of our patients have delayed gross motor development, and the remaining two are markedly delayed compared with their older siblings.
CONCLUSIONS: Cochlear implantation can be performed safely and with good results in children with JLNS, but requires knowledge of the diagnosis and necessary precautions have to be taken. ECG should be taken for all children with congenital deafness, preferably before exposure to strong sound stimuli. Vestibular dysfunction seems to be a part of JLNS, but this needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595190     DOI: 10.1097/aud.0b013e3181645393

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  6 in total

1.  Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis.

Authors:  Robert W Eppsteiner; A Eliot Shearer; Michael S Hildebrand; Adam P Deluca; Haihong Ji; Camille C Dunn; Elizabeth A Black-Ziegelbein; Thomas L Casavant; Terry A Braun; Todd E Scheetz; Steven E Scherer; Marlan R Hansen; Bruce J Gantz; Richard J H Smith
Journal:  Hear Res       Date:  2012-08-28       Impact factor: 3.208

2.  Outcomes of Cochlear Implantation in Patients with Jervell and Lange-Nielsen Syndrome: A Systematic Review and Narrative Synthesis.

Authors:  Chris Metcalfe; Jameel Muzaffar; Peter Monksfield; Manohar Bance
Journal:  J Int Adv Otol       Date:  2020-12       Impact factor: 1.017

Review 3.  Cochlear implantation in common forms of genetic deafness.

Authors:  Richard J Vivero; Kenneth Fan; Simon Angeli; Thomas J Balkany; Xue Z Liu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-07-22       Impact factor: 1.675

4.  New criteria of indication and selection of patients to cochlear implant.

Authors:  André L L Sampaio; Mercêdes F S Araújo; Carlos A C P Oliveira
Journal:  Int J Otolaryngol       Date:  2011-10-13

5.  Jervell and Lange-Nielsen Syndrome due to a Novel Compound Heterozygous KCNQ1 Mutation in a Chinese Family.

Authors:  Yue Qiu; Sen Chen; Xia Wu; Wen-Juan Zhang; Wen Xie; Yuan Jin; Le Xie; Kai Xu; Xue Bai; Hui-Min Zhang; Xiao-Zhou Liu; Xiao-Hui Wang; Yu Sun; Wei-Jia Kong
Journal:  Neural Plast       Date:  2020-05-16       Impact factor: 3.599

6.  Novel frameshift mutation in the KCNQ1 gene responsible for Jervell and Lange-Nielsen syndrome.

Authors:  Azam Amirian; Seyed Mohammad Dalili; Zahra Zafari; Siamak Saber; Morteza Karimipoor; Vahid Akbari; Amir Farjam Fazelifar; Sirous Zeinali
Journal:  Iran J Basic Med Sci       Date:  2018-01       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.